Ying-jie Zhao
Hefei, 230601, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting FOSL1-KCa3.1 inhibits ferroptosis and cartilage destruction by suppressing mitochondrial hyperfusion.
Journal: Acta pharmacologica Sinica
Published: December 19, 2025
Blockade of KCa3.1 ameliorates rheumatoid arthritis by suppressing macrophage M1 polarization via the NLRP3 inflammasome signaling pathway.
Journal: European journal of pharmacology
Published: June 29, 2025
Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies.
Journal: Autoimmunity reviews
Published: January 26, 2024
Calcium-Permeable Channels Cooperation for Rheumatoid Arthritis: Therapeutic Opportunities.
Journal: Biomolecules
Published: July 29, 2022
Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis.
Journal: Frontiers in immunology
Published: July 19, 2022
Modulators of ASIC1a and its potential as a therapeutic target for age-related diseases.
Journal: Ageing research reviews
Published: June 24, 2022
Transient receptor potential melastatin 7 and their modulators.
Journal: European journal of pharmacology
Published: April 06, 2022
Acid-sensitive ion channel 1a mediates osteoarthritis chondrocyte senescence by promoting Lamin B1 degradation.
Journal: Biochemical pharmacology
Published: March 01, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026